Bank of Montreal Can Sells 1,981 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Bank of Montreal Can lessened its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 289,102 shares of the medical instruments supplier’s stock after selling 1,981 shares during the quarter. Bank of Montreal Can’s holdings in DENTSPLY SIRONA were worth $7,820,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XRAY. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 753 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in DENTSPLY SIRONA during the third quarter worth about $27,000. LRI Investments LLC increased its holdings in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 564 shares in the last quarter. Kennebec Savings Bank acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter worth approximately $35,000. Finally, Rothschild Investment LLC acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $32,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY opened at $19.82 on Tuesday. The firm’s 50 day simple moving average is $22.43 and its 200 day simple moving average is $24.68. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The company has a market capitalization of $3.94 billion, a price-to-earnings ratio of -9.57, a P/E/G ratio of 1.93 and a beta of 0.97. DENTSPLY SIRONA Inc. has a fifty-two week low of $17.21 and a fifty-two week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. During the same quarter in the previous year, the business posted $0.49 EPS. DENTSPLY SIRONA’s revenue for the quarter was up .4% on a year-over-year basis. As a group, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on XRAY. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.